ONYX-015 engineered adenovirus that replicates in and kills tumor cells deficient in the p53 tumor suppressor gene data

Researchers reported at the American Society of Clinical Oncology meeting in Denver that ONXX's

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE